Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
| Product: | ILARIS |
| Active Ingredient: | Canakinumab 150mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturer: | Novartis Pharma Stein AG, Stein, Switzerland |
| Product: | Leqvio |
| Active Ingredient: | Inclisiran sodium 200mg/mL equivalent to inclisiran 189mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Novartis New Zealand Limited |
| Manufacturers: | Corden Pharma SpA, Caponago, Italy Novartis Pharmaceutical Manufacturing GmbH, Langkampfen, Austria |
| Product: | Lidocaine Gel 2% |
| Active Ingredient: | Lidocaine hydrochloride monohydrate 2.2%w/w |
| Dosage Form: | Topical gel |
| New Zealand Sponsor: | Orion Laboratories (NZ) Limited |
| Manufacturer: | Orion Laboratories Pty Limited t/a Evaris Pharma, Perth, Australia |
| Product: | Mucosoothe |
| Active Ingredient: | Lidocaine hydrochloride monohydrate 21.3mg/mL equivalent to lidocaine hydrochloride 2%w/v |
| Dosage Form: | Oral topical gel |
| New Zealand Sponsor: | Orion Laboratories (NZ) Limited |
| Manufacturer: | Orion Laboratories Pty Limited t/a Evaris Pharma, Perth, Australia |
| Product: | Ozempic (2mg/1.5mL) |
| Active Ingredient: | Semaglutide 1.34mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Novo Nordisk Pharmaceuticals Limited |
| Manufacturers: | Novo Nordisk A/S, Copenhagen, Denmark Novo Nordisk A/S, Hillerod, Denmark |
| Product: | Ozempic (4mg/3mL) |
| Active Ingredient: | Semaglutide 1.34mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Novo Nordisk Pharmaceuticals Limited |
| Manufacturers: | Novo Nordisk A/S, Copenhagen, Denmark Novo Nordisk A/S, Hillerod, Denmark Novo Nordisk Pharmaceutical Industries, North Carolina, United States of America |
| Product: | Perrigo Surgi-Prep C Pink |
| Active Ingredients: | Chlorhexidine gluconate 26.625g/L Ethanol 586.98g/L |
| Dosage Form: | Topical solution |
| New Zealand Sponsor: | Orion Laboratories (NZ) Limited |
| Manufacturer: | Orion Laboratories Pty Limited t/a Evaris Pharma, Perth, Australia |
| Product: | Perrigo Surgi-Prep C Red |
| Active Ingredients: | Chlorhexidine gluconate 26.625g/L Ethanol 586.98g/L |
| Dosage Form: | Topical solution |
| New Zealand Sponsor: | Orion Laboratories (NZ) Limited |
| Manufacturer: | Orion Laboratories Pty Limited t/a Evaris Pharma, Perth, Australia |
| Product: | Perrigo Surgi-Prep C+ Pink |
| Active Ingredients: | Chlorhexidine gluconate 106.5g/L Ethanol 586.95g/L |
| Dosage Form: | Topical solution |
| New Zealand Sponsor: | Orion Laboratories (NZ) Limited |
| Manufacturer: | Orion Laboratories Pty Limited t/a Evaris Pharma, Perth, Australia |
| Product: | Perrigo Surgi-Prep C+ Red |
| Active Ingredients: | Chlorhexidine gluconate 106.5g/L Ethanol 586.98g/L |
| Dosage Form: | Topical solution |
| New Zealand Sponsor: | Orion Laboratories (NZ) Limited |
| Manufacturer: | Orion Laboratories Pty Limited t/a Evaris Pharma, Perth, Australia |
| Product: | Riodine Antiseptic Solution |
| Active Ingredient: | Povidone-iodine 100mg/mL equivalent to iodine 1.0%w/v |
| Dosage Form: | Topical solution |
| New Zealand Sponsor: | Orion Laboratories (NZ) Limited |
| Manufacturer: | Orion Laboratories Pty Limited t/a Evaris Pharma, Perth, Australia |
| Product: | Ritemvia (100mg/10mL) |
| Active Ingredient: | Rituximab 10mg/mL |
| Dosage Form: | Concentrate for infusion |
| New Zealand Sponsor: | Celltrion Healthcare New Zealand Limited |
| Manufacturer: | Celltrion Inc., Incheon, South Korea |
| Product: | Ritemvia (500mg/50mL) |
| Active Ingredient: | Rituximab 10mg/mL |
| Dosage Form: | Concentrate for infusion |
| New Zealand Sponsor: | Celltrion Healthcare New Zealand Limited |
| Manufacturer: | Celltrion Inc., Incheon, South Korea |
| Product: | Truxima (100mg/10mL) |
| Active Ingredient: | Rituximab 10mg/mL |
| Dosage Form: | Concentrate for infusion |
| New Zealand Sponsor: | Celltrion Healthcare New Zealand Limited |
| Manufacturer: | Celltrion Inc., Incheon, South Korea |
| Product: | Truxima (500mg/50mL) |
| Active Ingredient: | Rituximab 10mg/mL |
| Dosage Form: | Concentrate for infusion |
| New Zealand Sponsor: | Celltrion Healthcare New Zealand Limited |
| Manufacturer: | Celltrion Inc., Incheon, South Korea |
| Product: | Wegovy |
| Active Ingredient: | Semaglutide 0.68mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Novo Nordisk Pharmaceuticals Limited |
| Manufacturers: | Novo Nordisk A/S, Hovedstaden, Denmark Novo Nordisk A/S, Hillerod, Denmark |
| Product: | Wegovy (0.5mg FlexTouch) |
| Active Ingredient: | Semaglutide 1.34mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Novo Nordisk Pharmaceuticals Limited |
| Manufacturers: | Novo Nordisk A/S, Hovedstaden, Denmark Novo Nordisk A/S, Hillerod, Denmark |
| Product: | Wegovy (1mg FlexTouch) |
| Active Ingredient: | Semaglutide 1.34mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Novo Nordisk Pharmaceuticals Limited |
| Manufacturers: | Novo Nordisk A/S, Hovedstaden, Denmark Novo Nordisk A/S, Hillerod, Denmark |
| Product: | Wegovy |
| Active Ingredient: | Semaglutide 2.27mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Novo Nordisk Pharmaceuticals Limited |
| Manufacturers: | Novo Nordisk A/S, Hovedstaden, Denmark Novo Nordisk A/S, Hillerod, Denmark |
| Product: | Wegovy |
| Active Ingredient: | Semaglutide 3.2mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Novo Nordisk Pharmaceuticals Limited |
| Manufacturers: | Novo Nordisk A/S, Hovedstaden, Denmark Novo Nordisk A/S, Hillerod, Denmark |
Dated this 15th day of August 2025.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).